Recent Quotes

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		-0.120		-0.110		0.0100
REV		19.770M		19.866M		96.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TXMD	TherapeuticsMD	1.20	0.01	0.84%		467.9M

TherapeuticsMD Frequently Asked Questions

How do I buy TherapeuticsMD (TXMD) stock?

You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.

View our list of the best stock brokerages.

Who are TherapeuticsMD's (TXMD) competitors?

Other companies in TherapeuticsMD’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Aerie Pharmaceuticals (NASDAQ:AERI), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and BioDelivery Sciences Intl (NASDAQ:BDSI).

What is the target price for TherapeuticsMD (TXMD) stock?

The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Jefferies on August 7, 2020. The analyst firm set a price target for 1.20 expecting TXMD to rise to within 12 months (a possible 0.84% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for TherapeuticsMD (TXMD)?

The stock price for TherapeuticsMD (NASDAQ: TXMD) is $1.19 last updated Today at 8:00:02 PM.

Does TherapeuticsMD (TXMD) pay a dividend?

There are no upcoming dividends for TherapeuticsMD.

When is TherapeuticsMD (NASDAQ:TXMD) reporting earnings?

TherapeuticsMD’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is TherapeuticsMD (TXMD) going to split?

There is no upcoming split for TherapeuticsMD.

What sector and industry does TherapeuticsMD (TXMD) operate in?

TherapeuticsMD is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.